CircuLex PCSK9 R194A (Human) of 20 μg and The PCSK9 R194A demonstrates 64 kDa (catalytic and C-terminal domain) and 16 kDa (prodomain) by SDS-PAGE analysis.
| Product Specifications | |
| Gene ID - Human | |
| Gene ID - Mouse | |
| Purity | The PCSK9 R194A is greater than 95% pure as determined by SDS-PAGE analysis. |
| Formulation | The PCSK9 R194A is supplied frozen in PBS pH 7.2, 10 % glycerol. |
| Citations for CircuLex PCSK9 R194A (Human) – 1 Found |
| Hyrina, Anastasia; Olmstead, Andrea D; Steven, Paul; Krajden, Mel; Tam, Edward; Jean, François. Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9. Ebiomedicine. 2017;23:68-78. PubMed |